Therapeutic agent for skin or skin repair-promoting agent comprising ghrelin, derivative thereof or substance capable of acting on GHS-R1a as active ingredient

Details for Australian Patent Application No. 2006316100 (hide)

International Classifications

Event Publications

22 May 2008 PCT application entered the National Phase

PCT publication WO2007/058359 Priority application(s): WO2007/058359

12 August 2010 Alteration of Name

The name of the applicant has been altered to University of Miyazaki; Japan as represented by President of National Cardiovascular Center; Daiichi Sankyo Company, Limited

27 October 2011 Alteration of Name

The name of the applicant has been altered to University of Miyazaki; National Cerebral and Cardiovascular Center; Daiichi Sankyo Company, Limited Amendments

1 December 2011 Application Accepted

Published as AU-B-2006316100

12 April 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under reg. 22.2I(2). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.